For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

“Portland had a much more entrepreneurial, pioneering spirit,” he says. “It was, yes, that makes sense. Let’s give that a try ...

Kolibaba, KS, Druker BJ. Current Status of Treatment for Chronic Myelogenous Leukemia. MedGenMed 2(2), 2000 [formerly published in Medscape Hematology-Oncology eJournal 3(2), 2000]. Available at ...

In addition to developing WU-CART-007, a drug candidate in clinical trials for treating relapsed or refractory T-cell acute ...

CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...

Targeted therapy revolutionized cancer treatment, with gene fusions leading the way when the FDA approved imatinib in 2001 to ...

In honor of National Family Caregivers Month, Certification for Long-Term Care (CLTC) has launched an inspiring new video series, "What it Means to Care in America: Real People. Real Stories. Real ...

ALBANY, N.Y., Nov. 12, 2024 /PRNewswire/ -- The New York StateWide Senior Action Council (StateWide), an organization dedicated to advocacy for the rights of seniors in New York State, today announced ...

A husband and wife, both with the type of leukemia featured in the movie 'Dying to Survive,' have shared the stories of their long-term fight with the disease at the on-going CIIE.

A new approach helps examine the proportion of cancerous and healthy stem cells in patients with chronic myeloid leukemia and how this influences treatment outcomes.